1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 02 MARCH 2015

Key Pharma News 02 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 33 pages

Industry Trend Analysis - Targeted Medicine Increasing Orphan Diseases
Industry Trend Analysis - BMS Making Waves In Future Of Onco-Immunotherapy With Two Transactions
Industry Trend Analysis - Complex Sofosbuvir Relationship Favours Mylan
Industry Brief - Merck Takes Full Promotional Responsibility For Erbitux In Japan
Industry Brief - Sanofi To Lay Off 100 Massachusetts Workers
Industry Brief - Actavis To Divest Pharmatech To TPG
Industry Brief - Shire Completes Acquisition Of NPS Pharma
Industry Brief - AstraZeneca Pays USD7.9mn To Settle Kickback Allegations Over Pricing
Industry Brief - Sanofi Appoints Brandicourt As CEO
Industry Brief - GSK Set To Complete Acquisition Of Novartis' Vaccines Business
Industry Trend Analysis - Actavis' Future Dominated By Brands, But Generics Remain Important
Industry Brief - Actavis To Adopt Allergan Name
Industry Trend Analysis - Array To Benefit From Novartis' GSK Oncology Acquisition
Industry Trend Analysis - Salix Acquisition Will Give Valeant A Toehold In Autoimmune Arena
Industry Trend Analysis - Pharmacyclics Seeking Potential Suitors
Industry Trend Analysis - NICE Recommendation Likely For Europe's First Stem Cell Therapy
Industry Trend Analysis - Avycaz Approval Is First Of Many Branded Blockbusters Expected For Actavis
Industry Trend Analysis - Lenvima TC Approval Provides Option For Large Unmet Medical Need
Industry Trend Analysis - HIV Market Set To Expand Gradually; Gilead To Uphold Leadership Despite ViiV
Industry Brief - Savaysa Available In US Pharmacies
Industry Trend Analysis - New ACA Initiative To Be Tested To Manage Rising Cancer Costs And Improve Cancer Care
Industry Brief - FDA Grants Priority Review For Cobimetinib/Zelboraf Combination In Advanced Melanoma
Industry Brief - E Keppra Approved In Japan For Additional Indication As MT For POS
Industry Brief - Novartis' LCZ696 Gains FDA Priority Review For HFrEF
Industry Trend Analysis - Patent Ruling Edges Pulmicort Respules Toward Lifecycle End
Industry Brief - Hospira Launches Inflectra In Remaining European Countries
Industry Brief - Teva Launches Enoxaparin And Linezolid Products In US
Industry Brief - Apotex' Second Biosimilar Application Accepted By FDA
Industry Brief - FDA Expands Indication for Revlimid/Dexamethasone Combination
Industry Brief - Seattle Genetics Submits Adcetris sBLA For Post-Transplant HL
Industry Brief - FDA Accepts Rapamune sNDA For Priority Review In LAM
Industry Brief - Eisai Meets Paediatric Needs With Tambocor Fine Granule Formulation
Industry Brief - Bayer's Adempas Approved In Japan For PAH
Industry Brief - FDA Approves Novartis' Farydak For MM
Industry Brief - Abraxane Reimbursed In Italy For First-Line MPC
Industry Trend Analysis - In Vitro Diagnostics Impacting Pharmaceutical R&D
Industry Trend Analysis - BMS And Gilead Equalise In HCV/HIV Co-Infection Phase III Results
Industry Brief - Lilly Delays Regulatory Submission Of Basal Insulin Peglispro
Industry Trend Analysis - J&J Guiding Drug Development With New Research Platforms
Industry Brief - Lilly Accepts Recommendation To Extend Evacetrapib Phase III Trial
Industry Trend Analysis - Motesanib Likely To Be Shelved After Another Phase III Failure

Table Of Contents

Key Pharma News 02 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.